Newsroom
Altratech completes HIV study with CUH, secures €3.5M funding to advance its novel technology to clinical trials
Altratech is developing a portable RNA kit, a device capable of diagnosing viruses such as HIV, Ebola and zika without the need for a lab.
Altratech presents at NextGenDx 2020
At NextGenDx conference (Aug 2020), Altratech presented “Novel Techniques for POC Disease Monitoring Utilizing Programmable Molecular Velcro” These advanced PNA probes were co-developed by Altratech and NIH, and jointly filed in a US patent disclosure
Altratech selected as a top-25 Medtech Showcase Accelerator startup
MedTech Innovator Selects 50 Best-in-Class Startups for 2019 Showcase and Accelerator
Altratech launches its ROCAP PNA-probe design-tool at Medica 2018
PNA probes have different design rules to other oligomer probes. Altratech has developed a PNA-probe design tool “ROCAP” and launched it today at Medica 2018. It is in beta use at Altratech, at partners, and at NIH in US
Limerick’s Altratech secures €5.2m in funding
Limerick-based Altratech has raised €5.2m after Bank of Ireland's Kernel Capital Growth Fund and Infinity Capital led a €2.2m investment, while the company also secured €3m in EU Horizon 2020 funding. Altratech is developing a single-use portable semiconductor test kit Read More
Altratech awarded €3M H2020 SME-Instrument grant for HIV study
A SHANNON company is set to receive a share of €10 million in funding from the EU’s scientific research fund. AltraTech has been named among five small Irish companies with big ideas awarded with the funding to help get their Read More
